Physician profile
Bertram E Yuh
NPI 1306008164
$197,254.90
in general payments reported to CMS, 2019-2025
21 companies · $51K in 2025
The $51K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.15 · 2020: $350 · 2021: $3,634 · 2022: $1,852 · 2023: $39K · 2024: $101K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $131K · Travel and Lodging: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $9,896 · Consulting Fee: $5,496 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $130,549.61 |
| Travel and Lodging | $32,238.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,800.00 |
| Food and Beverage | $9,896.08 |
| Consulting Fee | $5,496.00 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $178,606.90 | 2021-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Virtual Incision Corporation | $7,098.00 | 2024 | Mira |
| Vascular Technology, INC. | $4,320.00 | 2024-2025 | |
| Profound Medical Corp. | $1,741.94 | 2025 | Tulsa-Pro |
| Palette Life Sciences, INC. | $1,390.86 | 2023 | |
| Angiodynamics, INC. | $1,201.68 | 2024-2025 | Nanoknife |
| Verathon INC. | $500.00 | 2024 | Npd Clinical Study |
| Endo Pharmaceuticals INC. | $500.00 | 2023 | |
| Urogen Pharma, INC. | $419.96 | 2022-2025 | Jelmyto |
| Bard Peripheral Vascular, INC. | $400.00 | 2023 | |
| Genzyme Corporation | $350.00 | 2020 | |
| Leica Microsystems INC. | $176.00 | 2024 | |
| Janssen Scientific Affairs, LLC | $143.01 | 2023 | Erleada |
| Olympus America INC. | $135.83 | 2025 | Hd Camera Head |
| Medtronic, INC. | $90.00 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $54.62 | 2024 | Adstiladrin |
| Merck Sharp & Dohme LLC | $52.13 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $21.32 | 2024 | Akeega, Balversa, Erleada |
| 180 Medical, INC. | $19.37 | 2019 | |
| Ethicon US, LLC | $18.78 | 2019 | |
| Coloplast Corp | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertram Yuh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.